Generic Product News (April 2016)

Pharmacy TimesApril 2016 Respiratory Health
Volume 82
Issue 4

Read about the new generic products featured in April.

Teva Pharmaceuticals

Compare to: Taxotere Injection Concentrate (sanofi-aventis)

Indication: Teva Pharmaceuticals has announced the launch of Docetaxel Injection USP, the therapeutic equivalent of Sanofi’s Taxotere Injection Concentrate. The product is a microtubule inhibitor indicated for the treatment of breast cancer, non— small cell lung cancer, hormone-refractory prostate cancer, gastric adenocarcinoma, and locally advanced squamous cell carcinoma of the head and neck.

Dosage Form: Intravenous injection: 20 mg/mL

For More Information:

Frovatriptan Succinate Tablets, 2.5 Mg Marketed by: Glenmark Pharmaceuticals, Inc

Compare to: Frova (Endo Pharmaceuticals, Inc)

Indication: Glenmark Pharmaceuticals is now shipping its Frovatriptan Succinate Tablets, 2.5 mg, the therapeutic equivalent of Endo Pharmaceuticals’ Frova tablets. The product is indicated for the acute treatment of migraine with or without aura in adults. The recommended dose is a single tablet taken orally with fluids.

Dosage Form: Tablets: 2.5 mg

For More Information:

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateMarketed by: Impax Laboratories, Inc

Compare to: Adderall XR (Shire)

Indication: The FDA has approved Impax Laboratories’ Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, the therapeutic equivalent of Shire’s Adderall XR. The product is indicated to treat patients with attentiondeficit/ hyperactivity disorder.

Dosage Form: Tablets: 5, 10, 15, 20, 25, and 30 mg

For More Information:

Theophylline Extended-Release TabletsMarketed by: Alembic Pharmaceuticals, Inc

Compare to: Theo-24 (Auxilium Pharmaceuticals, Inc)

Indication: Alembic Pharmaceuticals has just launched Theophylline Extended-Release Tablets, the generic equivalent to Auxilium Pharmaceuticals’ Theo-24 extendedrelease capsules, in 300-mg and 450-mg dosage strengths. The product is a bronchodilator used to treat breathing difficulty associated with asthma, chronic pulmonary obstructive disease, and emphysema.

Dosage Form: Tablets: 300 and 450 mg

For More Information:

Recent Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs